With pandemic hitting hard and affecting all spheres of life, science and research has buckled up and paced more than ever. There are many companies involved in an extensive research in life sciences, one of them being GeNext Genomics. Established in 2011, GeNext Genomics Pvt Ltd is an emerging life science research start up and contract research organization in central India, focused on providing purpose-based solution for life science customers. The CEO of the company is Mrs. Supriya Kashikar.
Since the Biotech Industry is dealing with life sciences, it needs to have lots of expectations from the CRO in order to make a quality product. The client’s satisfaction is influenced by a complex interplay of factors and is a challenging aspect. The quality of service and the turn-around time is the key criteria for being in the market, parallelly synchronized with a diverse set of client expectations. The company offers a complete handholding of the clients till manufacturing, offering full flexibility to help them meet their expectations.
Being An Indigenous Provider Gives GeNext a Competitive Edge
GeNext Genomics provides specialized services and being an indigenous provider, it has gained a
competitive edge over other MNCs in the country. With a Diverse Antibody Library Platform, it has managed to create a global client base outside the country, to serve the various targets and areas.
The company is a one stop solution for all Proteins and Antibodies, making it an exclusive over the others in the market. It has a proprietary platform for the development of antibodies for almost any target. GeNext Genomics has a platform for Limitless Monoclonal Antibodies as per the client’s choice. It hand holds its clients throughout the product life-cycle through their services.
GeNext Genomics has served various companies, academia with its niche platform to discover, develop and scaleup the product for commercialization. It also entered into a collaboration with many academic partners to develop diagnostic technology for them from the start. The company’s model is B2B services for industry partners, and it requires development and licensing out the technology platform. The services start right from target identification to the validation and development of technology. Thus, the services can be customized based on requirement.
We strive to get it right the first time
A Team of Scientists With An Experience In Academia & Industry
GeNext is a budding research-based company, with a highly specialized team involved in depth research in drug discovery services. Starting as a company based on identified gap of the Antibody development services in India, it is now among the few companies that provides these specialized services in India. Backed by a technical background, the research team is headed by Dr. Vinod Agarkar who is Protein Structural Biologist with exorbitant experience at Harvard Medical School and Harvard University, USA.
The company has various programs for making Antibody based discovery easy for its customer through its tech-platform. The future roadmap for GeNext Genomics is to develop a world class facility for development of cost-effective novel biologics development platform. This would help India to deliver its indigenous solution to the global population. GeNext is dedicated to a quality driven research with a focus to develop affordable healthcare solutions and address the unmet needs of the country.
